Clinical Trial Update: Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients

View source ↗

Summary

A clinical trial update indicates that fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass index (LVMI) and myoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Diskapi Teaching and Research Hospital | Conditions: Fibroblast | Status: UNKNOWN